Raymond James Financial Inc. bought a new stake in The Clorox Company (NYSE:CLX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 233,574 shares of the company's stock, valued at approximately $37,935,000. Raymond James Financial Inc. owned 0.19% of Clorox as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently modified their holdings of the business. Brooklyn Investment Group lifted its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC bought a new stake in Clorox during the third quarter worth about $27,000. Continuum Advisory LLC lifted its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after purchasing an additional 138 shares during the period. Asset Planning Inc bought a new stake in Clorox during the fourth quarter worth about $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in Clorox during the fourth quarter worth about $36,000. Institutional investors own 78.53% of the company's stock.
Analyst Ratings Changes
CLX has been the subject of a number of research reports. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Evercore ISI increased their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Barclays increased their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a report on Wednesday, February 5th. DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Finally, Wells Fargo & Company increased their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $159.62.
Read Our Latest Report on Clorox
Clorox Trading Up 0.3 %
NYSE:CLX traded up $0.37 on Friday, reaching $147.32. 1,035,843 shares of the stock traded hands, compared to its average volume of 1,217,296. The firm has a market capitalization of $18.15 billion, a price-to-earnings ratio of 40.25, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The company's 50 day moving average is $154.20 and its 200-day moving average is $160.20. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the firm posted $2.16 earnings per share. Equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.31%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio is presently 133.33%.
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.